Badar Ul Islam 1 , Syed Kashif Zaidi 2 , Mohammad Amjad Kamal 3 , Shams Tabrez 3 Show Affiliations »
Abstract
BACKGROUND: Alzheimer's disease (AD) is an irreversible multifaceted neurodegenerative disorder that gradually degrades neuronal cells. It is the most frequent cause of memory loss and dementia in elderly individuals worldwide. The extracellular deposition of beta amyloid (Aβ), intracellular neurofibrillary tangles (NFTs) retention, neuronal decline and neurotransmitter system derangement are the patho-physiological marker of this devastated disease Objective: In view of limited treatment option and their success rate, there is an urgent need to explore the vast array of proteomes for the management of AD. These proteins could be therapeutically targeted to prevent the progression of this disease. In the present review, we tried to uncover several proteins that could be exploited in AD therapeutics. CONCLUSION: Based on our article, we conclude that proteome based AD treatment needs more refinements and approaches to achieve the desired success rate. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
BACKGROUND: Alzheimer's disease (AD ) is an irreversible multifaceted neurodegenerative disorder that gradually degrades neuronal cells. It is the most frequent cause of memory loss and dementia in elderly individuals worldwide. The extracellular deposition of beta amyloid (Aβ), intracellular neurofibrillary tangles (NFTs) retention, neuronal decline and neurotransmitter system derangement are the patho-physiological marker of this devastated disease Objective: In view of limited treatment option and their success rate, there is an urgent need to explore the vast array of proteomes for the management of AD . These proteins could be therapeutically targeted to prevent the progression of this disease. In the present review, we tried to uncover several proteins that could be exploited in AD therapeutics. CONCLUSION: Based on our article, we conclude that proteome based AD treatment needs more refinements and approaches to achieve the desired success rate. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Entities: Disease
Gene
Keywords:
Alzheimer's disease; amyloid beta; amyloid precursor protein; apolipoprotein; tau; therapeutics
Mesh： See more »
Substances： See more »
Year: 2017
PMID： 28164752 DOI： 10.2174/1389200218666170203110135
Source DB: PubMed Journal: Curr Drug Metab ISSN： 1389-2002 Impact factor: 3.731